ClinicalTrials.gg
CompletedNCT06847880Updated Sep 3, 2026

The Potential Effect of the Local Administration of Vitamins C and E on Orthodontic Treatment: A Randomized Clinical Trial

A Phase 1 interventional study of 1: Vitamin C Supplementation and Vitamin E Supplementation in Pain Perception, Root Resorption and Rate of Orthodontic Tooth Movement, sponsored by University of Baghdad. Completed at 3 sites in Iraq. Open to participants aged 12 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-09-03.

Sponsored by University of Baghdad · Phase 1, Interventional, and Treatment

Phase
Phase 1
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
12 Years and older
Sex
All
01

Study summary

Brief Summary of the Study

This study investigates the effects of locally administered vitamins C and E on orthodontic tooth movement during the initial stage of treatment. Orthodontic tooth movement relies on bone remodeling, which can be influenced by antioxidants like vitamins C and E. Vitamin C promotes collagen formation and osteoblast activity, while vitamin E has anti-inflammatory and antioxidant properties that may impact bone metabolism.

The study is a randomized clinical trial conducted in multiple clinics, where patients will be divided into three groups:

  1. Control group - receives a saline injection.
  2. Vitamin C group - receives a local injection of vitamin C.
  3. Vitamin E group - receives a local injection of vitamin E.

Injections will be administered every two weeks for vitamin C and every month for vitamin E, for six months, while patients undergo orthodontic treatment with fixed appliances. Researchers will evaluate the rate of tooth movement, root resorption, pain perception, and patient experience. Additionally, biomarkers related to bone remodeling will be measured in gingival crevicular fluid at different time points.

The study aims to determine whether local administration of vitamins C or E enhances orthodontic tooth movement and elevate their effects on the orthodontic potential side effects like root resorption and pain. The findings may provide valuable insights into optimizing orthodontic treatment with the help of antioxidants.

Read the detailed description

This randomized clinical trial aims to investigate the effects of locally administered vitamins C and E on mandibular incisor crowding relief during the initial stage of orthodontic treatment. The study follows a multicenter, prospective, single-blind, parallel-group design with equal randomization (1:1:1) and is conducted at Bab Al-Muadham Dental Health Center and the Postgraduate Orthodontic Clinic, Department of Orthodontics, College of Dentistry, University of Baghdad. Participants were blinded to group allocation, while the principal investigator (A.M.H.) was aware of all group allocations throughout the study period.

Study Rationale Orthodontic tooth movement involves a complex biological process mediated by bone remodeling, which is regulated by mechanical forces and biochemical mediators. Oxidative stress and inflammatory responses play a significant role in the remodeling process. Vitamin C (ascorbic acid) and vitamin E (tocopherol) are known for their antioxidant properties and potential effects on bone metabolism, tissue healing, and inflammation modulation. This study aims to determine whether locally administered vitamins C and E can enhance orthodontic tooth movement, reduce adverse effects such as root resorption, and improve patient experience during treatment.

Study Objectives The primary objective is to compare the effectiveness of vitamin C and vitamin E injections versus a saline control in mandibular incisor crowding relief over 24 weeks.

The secondary objectives include:

Assessing the extent of apical root resorption using periapical radiographs. Evaluating pain perception using a 0-10 numerical rating scale (NRS) during the first seven days after each archwire placement.

Measuring patient perception of treatment experience through a structured questionnaire.

Analyzing levels of biomarkers associated with bone remodeling (RANKL, OPG, RUNX2) in gingival crevicular fluid (GCF) to determine the biological effects of the interventions.

Participant Selection Eligible participants are patients aged 12 years and older with moderate to very severe mandibular anterior crowding (Little's Irregularity Index [LII]). Exclusion criteria include systemic diseases, prior orthodontic treatment, or the use of medications that could influence bone metabolism or inflammatory responses.

Intervention Groups

Participants will be randomly assigned to one of three groups:

Control Group: Receives 0.6 mL of normal saline, divided among the six mandibular anterior teeth and administered every two weeks.

Vitamin C Group: Receives intraepidermal injection of vitamin C (120 mg in 1.2 mL, divided among six mandibular anterior teeth).

Vitamin E Group: Receives intraepidermal injection of vitamin E (15 mg in 0.1 mL, divided among six mandibular anterior teeth).

Injections are repeated biweekly for the vitamin C and control groups and monthly for the vitamin E group, for a total of six months (24 weeks).

A pilot phase included 10 participants. Four participants who received the initial vitamin E regimen of 60 mg in 0.4 mL every two weeks were excluded from the final analysis after the regimen was modified because of poor absorption of the oil-based formulation. The final vitamin E regimen was reduced to 15 mg in 0.1 mL and administered once monthly. The remaining participants in the vitamin C and control groups continued in the trial and were included in the final analysis.

Orthodontic Treatment Protocol

All participants undergo standardized orthodontic treatment using MBT brackets (0.022-inch slot). The leveling and alignment phase follows a sequential archwire progression with CuNiTi archwires in the following sequence:

0.014-inch CuNiTi (weeks 0-8) 0.016-inch CuNiTi (weeks 8-16) 0.018-inch CuNiTi (weeks 16-24)

Data Collection and Outcome Assessments

Data will be collected at multiple time points throughout the study:

  1. Mandibular Incisor Crowding Relief Direct intraoral scans obtained using the Heron™ intraoral scanner will be used to measure Little's Irregularity Index (LII) at baseline and every four weeks until week 24.
  2. Root Resorption Standardized periapical radiographs of both mandibular central incisors will be taken at baseline, 8 weeks, and 24 weeks. Root resorption will be assessed using corrected root-length measurements and the Malmgren scoring index.
  3. Pain Perception Participants will record the maximum mandibular tooth pain experienced once daily in the evening using a 0-10 NRS for seven days after each archwire placement.
  4. Patient Perception A 22-item bilingual questionnaire assessing pain, discomfort, swelling, numbness, functional difficulties, effects on daily activities, and overall perception of the intervention visit will be administered at 8 weeks.
  5. Biomarker Analysis Gingival crevicular fluid (GCF) samples will be collected at baseline, 1 week, and 4 weeks. Levels of RANKL, OPG, and RUNX2 will be analyzed to assess changes in bone remodeling activity.

Statistical Analysis

Data will be analyzed using SPSS version 26. Statistical methods will include:

Descriptive statistics (mean, standard deviation, frequency). Intraclass correlation coefficients and weighted kappa statistics for measurement reliability.

One-way analysis of variance, mixed-design repeated-measures analysis of variance, Kruskal-Wallis test, Wilcoxon signed-rank test, Pearson's chi-square test, and Friedman test.

A significance level of 0.05 will be used for hypothesis testing, with Bonferroni adjustment where applicable.

Study Oversight and Ethical Considerations The study is self-funded and complies with ethical guidelines for human research. Ethical approval was obtained from the Research Ethics Committee of the College of Dentistry, University of Baghdad, on 21 January 2025 (reference number 1014; project number 1014425). Written informed consent was obtained from adult participants. For participants younger than 18 years, written parental or guardian consent and participant assent were obtained before enrolment.

Potential Impact This trial may provide valuable insights into the role of antioxidant therapy in orthodontic treatment. If vitamins C and E positively influence tooth movement and root integrity, their use could enhance treatment efficiency while minimizing complications. Findings may also contribute to a better understanding of bone remodeling mechanisms in response to mechanical forces.

02

Conditions studied

  • Pain Perception
  • Root Resorption
  • Rate of Orthodontic Tooth Movement
  • Biomarkers

Browse trials for

Keywords

  • Orthodontic tooth movement
  • Root resorption
  • RANKL
  • Tooth alignment
  • Vitamin C
  • Vitamin E
  • Pain perception
  • Osteoprotegerin
  • RUNX2
03

In context

Root Resorption

43 studies on the registry are indexed under Root Resorption; 9 are open to participants now.

This study's enrollment of 56 is above the median of 29 across 36 interventional studies indexed under Root Resorption.

Browse Root Resorption studies →

Lead sponsor

University of Baghdad is the lead sponsor of 170 studies on the registry; 69 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
12 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Patients aged 12 years and above, who are indicated for fixed appliance orthodontic treatment.
  2. Patients with moderate to very severe crowding of the mandibular anterior teeth as per the Little's Irregularity Index (LII).
  3. Treatment with or without two mandibular first premolars extraction. Presence of all the mandibular permanent teeth, except the third molars.

5. The overbite and overjet should not impede bracket placement on the mandibular anterior teeth.

Exclusion criteria

Exclusion Criteria:

  1. History of previous orthodontic intervention.
  2. History of trauma or root resorption in the mandibular anterior teeth.
  3. Presence of mandibular anterior teeth crowding of less than 4 mm (LII).
  4. Existence of blocked-out teeth precluding engagement with the aligning archwire.
  5. History of systemic diseases, especially diabetes and bone diseases.
  6. Patients with periodontitis and obvious loss of tooth attachment according to Plaque and Bleeding on Probing indices.
  7. Pregnant and lactating mothers.
  8. Mouth breathing patients and smokers.
  9. Healthy patients who have not used any medications (such as anti-inflammatory or antimicrobial drugs) or supplements (such as vitamins)
05

Study design

Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Arm 1: Vitamin C Treatment

    This arm involves participants receiving Vitamin C to assess its effect on orthodontic tooth movement and crowding relief. The treatment aims to evaluate how Vitamin C influences the rate of tooth movement, as measured by Little's Irregularity Index (LII) over 24 weeks (the supposed end date of leveling and alignment stage).

    Drug: 1: Vitamin C Supplementation

  • Experimental
    Vitamin E Treatment

    Participants in this arm will receive Vitamin E to evaluate its effect on orthodontic tooth movement. The aim is to compare the efficacy of Vitamin E to Vitamin C and the saline control in terms of crowding relief and tooth alignment, measured using LII over a 24-week period (the supposed end date of leveling and alignment stage).

    Drug: Vitamin E Supplementation

  • Placebo comparator
    Arm 3: Saline Control

    This arm serves as the control group, where participants receive saline injections. The primary aim is to assess how saline compares with Vitamin C and Vitamin E treatments in terms of the rate of orthodontic tooth movement and crowding relief as measured by LII.

    Other: Saline Solution (Control)

Interventions

  • Drug1: Vitamin C Supplementation

    • Vitamin C (Ascorbic Acid): This intervention involves the administration of vitamin C, which is known for its antioxidant properties. The concentration will be 120 mg in 1.2 ml, and the produced volume will be divided by six lower anterior teeth; each tooth will receive 0.2 ml (20 mg) of the vitamin C. It is hypothesized to accelerate orthodontic tooth movement by reducing oxidative stress and promoting collagen synthesis.

  • DrugVitamin E Supplementation

    • Vitamin E (Tocopherol Acetate): This intervention uses vitamin E, another antioxidant, thought to reduce inflammation and support tissue repair, potentially improving the effectiveness of orthodontic treatment by enhancing tissue recovery and reducing side effects. The total dose was 15 mg in 0.1 mL, divided among the six mandibular anterior teeth; each tooth received 2.5 mg in approximately 0.02 mL. Vitamin E was administered once monthly for 24 weeks.

  • OtherSaline Solution (Control)

    Saline Solution (Control): The control group will receive a saline solution, which is a placebo, allowing for the comparison of the effects of vitamin C and vitamin E on orthodontic tooth movement without the influence of additional nutrients.

06

What researchers measure

Primary outcomes

  1. Difference in the amount of crowding relief of the mandibular incisors before treatment and at 4, 8, 12, 16, 20, and 24 weeks after the start of treatment among the two vitamins and control groups

    The amount of crowding relief will be measured using Little's Irregularity Index (LII) on 3D digital models of the mandibular anterior teeth. Pre-treatment (T0) and post-treatment models at 4, 8, 12, 16, 20, and 24 weeks will be compared. * Measurement method: Alginate impressions will be taken at each time point and converted into 3D digital models using a high-precision scanner. * Definition: LII quantifies anterior misalignment by summing the displacement between mesial and distal contact points of six mandibular incisors. * Units: Millimeters (mm), rounded to 0.01 mm. * Expected outcome: Greater LII reduction indicates a higher rate of tooth movement. * Comparison: The control (saline) group will be compared with the vitamin C and vitamin E groups to assess their effects on tooth movement.

    Time frame: The amount of crowding relief will be measured using Little's Irregularity Index (LII) on 3D digital models of the mandibular anterior teeth. Measurements will be taken at baseline (T0) and at 4, 8, 12, 16, 20, and 24 weeks to assess changes over time.

Secondary outcomes

  1. Pain Perception After Archwire Placement: A Visual Analog Scale Assessment

    Pain perception will be measured using a Visual Analog Scale (VAS), a commonly used tool in clinical settings to quantify subjective pain experiences. The VAS consists of a 10 cm line where participants mark their pain level. One end of the line represents "no pain" (score of 0), and the other end represents "worst pain imaginable" (score of 10). Participants will be asked to record their pain levels twice daily for the first 7 days following each archwire placement during the treatment phase.

    Time frame: From the placement of each archwire to 7 days post-placement.

  2. Amount of orthodontically-induced inflammatory root resorption (OIIRR) in the apical region of mandibular anterior teeth

    Measurement of the root resorption in the apical region of the mandibular anterior teeth, assessed through radiographs and calculated by comparing the root length and crown length.

    Time frame: Pre-treatment (T0), 8 weeks (T1), and 24 weeks (T2) after the start of treatment.

  3. Patient perception using a newly developed questionnaire for adjunctive orthodontic therapy

    Patients will complete a questionnaire to assess their perception of the treatment's comfort, side effects, and any additional effects due to vitamin administration during orthodontic therapy.

    Time frame: 8 weeks after the start of treatment.

  4. Levels of biomarkers (RANKL, OPG, and RUNX2) in gingival crevicular fluid (GCF):

    Measurement of the biomarkers in the GCF, which are involved in bone turnover and remodeling. These markers will help assess the biological effects of the vitamins on periodontal tissues during the initial stage of orthodontic treatment.

    Time frame: Pre-treatment (T0), 1 week (T1), and 4 weeks (T2) after the start of treatment.

07

Study locations

3 sites
  • Baghdad Al-Karkh Health Directorate, Baghdad, Iraq
    Baghdad, Baghdad Governorate 10013, Iraq
  • Baghdad Al-Rusafa Health Directorate
    Baghdad, Baghdad Governorate 10061, Iraq
  • College of Dentistry, University of Baghdad, Baghdad, Iraq
    Baghdad, Baghdad Governorate 10071, Iraq
08

References and documents

Publications

  • Bolat E, Esenlik E, Oncu M, Ozgocmen M, Avunduk MC, Yuksel O. Evaluation of the effects of vitamins C and E on experimental orthodontic tooth movement. J Dent Res Dent Clin Dent Prospects. 2020 Spring;14(2):131-137. doi: 10.34172/joddd.2020.0027. Epub 2020 Jun 17. PubMed 32908655 ↗
  • Yussif, N. (2019). Oral Mesotherapy: might be considered as an adjunctive technique for the different surgical procedures?. In Periodontal disease-diagnostic and adjunctive non-surgical considerations. IntechOpen.
  • Yussif, N.M.A., Dehis, H.M., Rahman, A.R.A., Aziz, M.A.W.M.A. and Yassin, M.M. (2018). Efficacy and safety of locally injectable vitamin C on accelerating the orthodontic movement of maxillary canine impaction (oral mesotherapy technique): prospective study. Clinical Cases in Mineral & Bone Metabolism, 15(2).
  • Mohsin MK, Qadir Omer Z. The effect of vitamin E incorporated into injectable platelet-rich fibrin on orthodontic tooth movement in rabbits. Cell Mol Biol (Noisy-le-grand). 2024 Jun 5;70(6):147-154. doi: 10.14715/cmb/2024.70.6.23. PubMed 38836668 ↗
  • Kappus H, Diplock AT. Tolerance and safety of vitamin E: a toxicological position report. Free Radic Biol Med. 1992;13(1):55-74. doi: 10.1016/0891-5849(92)90166-e. PubMed 1628854 ↗
  • Esenlik E, Naziroglu M, Acikalin C, Ovey IS. Vitamin E supplementation modulates gingival crevicular fluid lipid peroxidation and antioxidant levels in patients with orthodontic tooth movement. Cell Biochem Funct. 2012 Jul;30(5):376-81. doi: 10.1002/cbf.1833. Epub 2011 Nov 24. PubMed 22113708 ↗
  • Carr AC, Lykkesfeldt J. Discrepancies in global vitamin C recommendations: a review of RDA criteria and underlying health perspectives. Crit Rev Food Sci Nutr. 2021;61(5):742-755. doi: 10.1080/10408398.2020.1744513. Epub 2020 Mar 30. PubMed 32223303 ↗
  • Mucklow, J.C. (2000). Martindale: the complete drug reference. British journal of clinical pharmacology, 49(6), p.613.
  • Hathcock JN, Azzi A, Blumberg J, Bray T, Dickinson A, Frei B, Jialal I, Johnston CS, Kelly FJ, Kraemer K, Packer L, Parthasarathy S, Sies H, Traber MG. Vitamins E and C are safe across a broad range of intakes. Am J Clin Nutr. 2005 Apr;81(4):736-45. doi: 10.1093/ajcn/81.4.736. PubMed 15817846 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06847880
Responsible party
Ayat M. Hussein (Principal Investigator, University of Baghdad) — Principal investigator
First posted
Feb 26, 2025
Start date
Feb 27, 2025
Primary completion
Feb 28, 2026
Completion
Mar 28, 2026
Last update
Sep 3, 2026

Study contacts

Professor Dr. Yassir Abdulkadhim Yassir, Ph.D. (Orthodontics) (UK)
study director · University of Baghdad

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion